Facilitated By

San Antonio Medical Foundation

A PHASE III DOUBLE-BLIND, RANDOMIZED, MULTICENTER, CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF MEASLES, MUMPS, RUBELLA, VARICELLA (MMRV) VACCINE MADE WITH AN ALTERNATIVE MANUFACTURING PROCESS (AMP)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Infante,Anthony J
Funded by
MERCK SHARP & DOHME RESEARCH LTD
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Infectious Disease